Phase III trial of casopitant, a novel neurokinin-1 receptor antagonist, for the prevention of nausea and vomiting in patients receiving moderately emetogenic chemotherapy

Jørn Herrstedt, Wichit Apornwirat, Ahmed Shaharyar, Zeba Aziz, Fausto Roila, Simon Van Belle, Mark W Russo, Jeremey Levin, Salabha Ranganathan, Mary Guckert, Steven M Grunberg

    54 Citationer (Scopus)

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Phase III trial of casopitant, a novel neurokinin-1 receptor antagonist, for the prevention of nausea and vomiting in patients receiving moderately emetogenic chemotherapy'. Sammen danner de et unikt fingeraftryk.

    Pharmacology, Toxicology and Pharmaceutical Science

    Keyphrases